No title
During the recent decades, through the emerging of pump-based Parkinson (PD) therapies, it has been increasingly possible to manage motor fluctuations and dyskinesias, providing a stable levodopa plasma concentration. This can be carried out by continuous delivery of levodopa-carbidopa intestinal gel (LCIG) or levodopa-entacapone-carbidopa intestinal gel (LECIG) via a percutaneous endoscopic gastr
